Generic name, brand name (Indication for PBS listing) | No. of articles | Number of articles located | ||
---|---|---|---|---|
 |  | Articles in 6 months prior | Articles in PBAC meeting month | Articles 6 months post |
HPV vaccine | 1230 | 484 | 215 | 409 |
(NIP) | ||||
Trastuzumab †| 410 | 113 | 32 | 104 |
(Breast cancer) | ||||
Pemetrexed †| 83 | 20 | 39 | 16 |
(Mesothelioma) | ||||
Botulinum toxin | 71 | 11 | 1 | 26 |
(Spasticity) | ||||
Lapatinib †| 65 | 14 | 4 | 21 |
(Breast cancer) | ||||
Methylphenidate | 57 | 12 | 3 | 27 |
(ADHD) | ||||
Atomoxetine | 54 | 6 | 4 | 25 |
(ADHD) | ||||
Tdap vaccine | 53 | 9 | 4 | 20 |
(NIP) | ||||
Infliximab †| 49 | 12 | 3 | 32 |
(Crohn disease, psoriatic arthritis) | ||||
Rotavirus vaccine | 45 | 13 | 5 | 16 |
(NIP) | ||||
Varenicline | 39 | 1 | 1 | 24 |
(Smoking cessation) | ||||
Docetaxel †| 36 | 3 | 4 | 17 |
(Breast cancer, prostate cancer) | ||||
Fentanyl | 30 | 6 | 4 | 8 |
(Severe pain) | ||||
Sildenafil †| 28 | 5 | 0 | 0 |
(Pulmonary hypertension) | ||||
Paclitaxel | 27 | 3 | 3 | 11 |
(Breast cancer) | ||||
Imatinib †| 26 | 2 | 0 | 6 |
(Acute lymphoblastic leukaemia) | ||||
Ranibizumab †| 26 | 4 | 2 | 9 |
(Macular degeneration) | ||||
Natalizumab †| 21 | 2 | 0 |  |
(Multiple sclerosis) | ||||
Total | 2350 | 720 | 324 | 783 |